ZERO-COST BIOPHARMA RESEARCH TERMINAL · SEC EDGAR 424B / S-1

Biotech 424B Pipeline & Standard of Care Tracker

Automated extraction of drug development pipeline tables, clinical endpoints, and competitive comparison against existing Standard of Care (SoC) therapies directly from primary SEC filings.

Tracking 8 biopharma filings · Updated 2026-11-19 10:54 UTC
NASDAQ: TRAX 2026-11-04

First Tracks Biotherapeutics, Inc.

This prospectus supplement supplements information contained in the prospectus dated October 26, 2026 (the “Prospectus”), relating to the sale by the selli...

NASDAQ: LYCA 2026-10-23

Lycia Therapeutics, Inc.

While Xolair has validated IgE inhibition in food allergy, first-generation IgE blockers remain constrained by challenges that may limit treatment accessib...

NASDAQ: ADRX 2026-09-28

ADARx Pharmaceuticals, Inc.

The biopharmaceutical industry is characterized by rapidly advancing and changing technologies, intense competition and a strong emphasis on intellectual p...

NASDAQ: ETRA 2026-09-18

Electra Therapeutics, Inc.

The biopharmaceutical industry is characterized by rapidly evolving science and technology, intense competition, and a strong emphasis on intellectual prop...

NASDAQ: LTGO 2026-08-07

Latigo Biotherapeutics, Inc.

Today’s treatment paradigm for musculoskeletal pain consists of over-the-counter analgesics for mild to moderate symptoms, while moderate to severe pain is...

NASDAQ: PBLS 2026-06-10

Parabilis Medicines, Inc.

The pharmaceutical industry is characterized by rapid technological evolution and intense competition. We face and will continue to face competition from p...

NASDAQ: COAG 2026-05-01

Hemab Therapeutics Holdings, Inc.

The biotechnology and pharmaceutical industries are characterized by rapidly advancing innovative technologies under intense competition with an emphasis o...

NASDAQ: AVLN 2026-04-30

Avalyn Pharma Inc.

While there is no cure for pulmonary fibrosis, there are three FDA-approved therapies to treat pulmonary fibrosis: pirfenidone, or ESBRIET®, marketed by Le...